These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29038068)

  • 1. Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGFβ-receptor in the fibrotic kidney.
    Teekamp N; Van Dijk F; Broesder A; Evers M; Zuidema J; Steendam R; Post E; Hillebrands JL; Frijlink HW; Poelstra K; Beljaars L; Olinga P; Hinrichs WLJ
    Int J Pharm; 2017 Dec; 534(1-2):229-236. PubMed ID: 29038068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a sustained release formulation of PDGFβ-receptor directed carrier proteins to target the fibrotic liver.
    van Dijk F; Teekamp N; Beljaars L; Post E; Zuidema J; Steendam R; Kim YO; Frijlink HW; Schuppan D; Poelstra K; Hinrichs WLJ; Olinga P
    J Control Release; 2018 Jan; 269():258-265. PubMed ID: 29170138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor.
    van Dijk F; Teekamp N; Post E; Schuppan D; Kim YO; Zuidema J; Steendam R; Klose MHM; Meier-Menches SM; Casini A; Horvatovich PL; Sijbrandi NJ; Frijlink HW; Hinrichs WLJ; Poelstra K; Beljaars L; Olinga P
    J Control Release; 2019 Feb; 296():250-257. PubMed ID: 30682444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
    Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue.
    Beljaars L; Weert B; Geerts A; Meijer DK; Poelstra K
    Biochem Pharmacol; 2003 Oct; 66(7):1307-17. PubMed ID: 14505810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis.
    Poosti F; Bansal R; Yazdani S; Prakash J; Post E; Klok P; van den Born J; de Borst MH; van Goor H; Poelstra K; Hillebrands JL
    FASEB J; 2015 Mar; 29(3):1029-42. PubMed ID: 25466892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-induced drug targeting using novel peptide-ligand albumins.
    Meijer DK; Beljaars L; Molema G; Poelstra K
    J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis.
    Li Q; Yu Q; Ju J; You T; Yan Z; Nan X; Zhong J; Zhou JE
    Curr Pharm Des; 2017; 23(20):3034-3046. PubMed ID: 27928957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib microspheres based on [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers for ocular drug delivery.
    Ramazani F; Hiemstra C; Steendam R; Kazazi-Hyseni F; Van Nostrum CF; Storm G; Kiessling F; Lammers T; Hennink WE; Kok RJ
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):368-77. PubMed ID: 25701807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
    Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
    J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells.
    Dolman ME; Harmsen S; Pieters EH; Sparidans RW; Lacombe M; Szokol B; Orfi L; Kéri G; Storm G; Hennink WE; Kok RJ
    Int J Nanomedicine; 2012; 7():417-33. PubMed ID: 22334775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
    Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M
    Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advance in Polymer Based Microspheric Systems for Controlled Protein and Peptide Delivery.
    Yang Y; Chen Q; Lin J; Cai Z; Liao G; Wang K; Bai L; Zhao P; Yu Z
    Curr Med Chem; 2019; 26(13):2285-2296. PubMed ID: 30963961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
    Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
    Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth.
    Bansal R; Tomar T; Ostman A; Poelstra K; Prakash J
    Mol Cancer Ther; 2012 Nov; 11(11):2419-28. PubMed ID: 22933708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
    Malipeddi VR; Dua K; Awasthi R
    Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
    Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
    J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L; V G S; Vavia P
    Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.